Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
67.18
+1.25 (1.90%)
At close: Oct 30, 2026, 4:00 PM EDT
67.25
+0.07 (0.10%)
After-hours: Oct 30, 2026, 7:32 PM EDT
Royalty Pharma Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,536 | 2,378 | 2,264 | 2,355 | 2,237 | 2,289 |
Revenue Growth | 10.01% | 5.06% | -3.86% | 5.24% | -2.28% | 7.87% |
Gross Profit Gross Profit Growth | 2,430 | 2,674 | 1,531 | 1,794 | 1,333 | 1,837 |
Operating Income Operating Income Growth | 1,552 | 1,560 | 1,292 | 1,492 | 922.89 | 1,431 |
Net Income Net Income Growth | 811.99 | 770.95 | 858.98 | 1,135 | 42.83 | 619.73 |
Earnings Per Share EPS Growth | 1.86 | 1.78 | 1.91 | 2.53 | 0.10 | 1.49 |
EPS Growth | -19.98% | -6.83% | -24.54% | 2490.74% | -93.44% | 12.97% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cystic Fibrosis Franchise Cystic Fibrosis Franchise Growth | 855.89 | 828.18 | 826.21 | 852.31 | 808.95 | 762.89 |
Evrysdi Evrysdi Growth | 221.14 | 206.97 | 224.43 | 97.74 | - | - |
Trelegy Trelegy Growth | 160.44 | 154.1 | 146.92 | 128.05 | 57.93 | - |
Tremfya Tremfya Growth | 191.36 | 152.94 | 147.14 | 149.72 | 109.8 | 16.71 |
Voranigo Voranigo Growth | 172.98 | 154.42 | 46.15 | - | - | - |
Tysabri Tysabri Growth | 111.38 | 116.88 | 124.82 | 167.54 | 207.16 | 211.42 |
Other Products Other Products Growth | 691.07 | 647.67 | 633.76 | 629.24 | 630.33 | 507.52 |
Other Royalty Income and Other Royalty Income and Growth | 131.74 | 117.04 | 114.15 | 156.8 | 112.12 | 224.38 |
Revenue (Total) Revenue (Total) Growth | 2,536 | 2,378 | 2,264 | 2,355 | 2,237 | 2,289 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 836.99 | 637.5 | 987.23 | 495.31 | 1,736 | 2,189 |
Total Debt Total Debt Growth | 8,962 | 8,970 | 7,612 | 6,135 | 7,116 | 7,096 |
Net Cash (Debt) Net Cash Growth | -8,125 | -8,333 | -6,625 | -5,640 | -5,380 | -4,907 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -14.56 | -14.76 | -11.15 | -9.35 | -12.28 | -11.83 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 2,976 | 2,490 | 2,769 | 2,988 | 2,144 | 2,018 |
Free Cash Flow Free Cash Flow Growth | 2,976 | 2,490 | 2,769 | 2,988 | 2,144 | 2,018 |
Free Cash Flow Growth | 23.70% | -10.08% | -7.32% | 39.36% | 6.27% | -0.84% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 95.82% | 112.44% | 67.64% | 76.19% | 59.58% | 80.22% |
Operating Margin | 61.22% | 65.58% | 57.10% | 63.37% | 41.25% | 62.49% |
Pretax Margin | 53.11% | 55.68% | 58.79% | 72.20% | 10.28% | 54.21% |
Profit Margin | 32.02% | 32.42% | 37.95% | 48.20% | 1.92% | 27.07% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.940 | 0.880 | 0.840 | 0.800 | 0.760 | 0.680 |
Dividend Per Share Growth | 6.82% | 4.76% | 5.00% | 5.26% | 11.77% | 126.67% |
Dividend Yield | 1.40% | 2.28% | 3.31% | 2.86% | 1.93% | 1.72% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 36.03 | 21.41 | 13.20 | 11.01 | 407.00 | 27.62 |
Forward PE | 12.19 | 7.70 | 6.10 | 7.47 | 10.32 | 13.00 |
PS Ratio | 15.23 | 6.94 | 5.01 | 5.31 | 7.79 | 7.48 |